What are the treatment recommendations for relapsed or refractory CD33-positive acute myeloid leukemia (AML)?

Updated: Dec 05, 2018
  • Author: Karen Seiter, MD; Chief Editor: Emmanuel C Besa, MD  more...
  • Print
Answer

Answer

For relapsed or refractory CD33-positive AML (single-agent regimen) [11] :

  • Gemtuzumab 3 mg/m 2 (up to one 4.5-mg vial) on days 1, 4, and 7

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!